Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06339827 · ClinicalTrials.gov registry record · NA
ASk Questions in GYnecologic Oncology (ASQ-GYO)
A NA study of Ovarian Cancer and Endometrial Cancer, sponsored by Ira Winer.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06339827: Recruiting NA study of Ovarian Cancer and Endometrial Cancer, sponsored by Ira Winer.
NCT06339827 is a NA study of Ovarian Cancer and Endometrial Cancer that is actively recruiting participants, run by Ira Winer. The registered enrollment target is 70 participants, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06339827, a NA study of Ovarian Cancer and Endometrial Cancer, is actively recruiting participants, sponsored by Ira Winer.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also to determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.
Primary Outcome
The Perceived Efficacy in Patient-Provider Interactions (PEPPI) instrument is a validated, 20-item, 5-point Likert scale tool designed to measure patient's self-efficacy in obtaining medical information and attention to their medical concerns from physicians.
Conditions Studied
Interventions
- BEHAVIORAL Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List
Study Locations (1)
Michigan
- Barbara Ann Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-04-04 |
| Est. Completion | 2028-05 |
| Phase | NA |
What NCT06339827 shows while recruiting
NCT06339827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower).
The record links to 6 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List is the first listed.
NCT06339827 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06339827 about?
NCT06339827 is a clinical study titled "ASk Questions in GYnecologic Oncology (ASQ-GYO)". The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also t...
What is the current status of trial NCT06339827?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-04. Estimated completion is 2028-05.
What conditions does trial NCT06339827 study?
This clinical trial studies the following conditions: Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Vulvar Cancer, Vaginal Cancer.
What interventions are being tested in trial NCT06339827?
The interventions under investigation include: Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List (BEHAVIORAL).
Who is sponsoring clinical trial NCT06339827?
This trial is sponsored by Ira Winer, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06339827 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06339827's enrollment target sits among peer trials
70 177th of 322 higher than 140 of 322 other Ovarian Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
-
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI